How depression and antidepressant drugs affect endocannabinoid system?-review of clinical and preclinical studies
- PMID: 38280009
- DOI: 10.1007/s00210-023-02938-z
How depression and antidepressant drugs affect endocannabinoid system?-review of clinical and preclinical studies
Abstract
As major depressive disorder is becoming a more and more common issue in modern society, it is crucial to discover new possible grip points for its diagnosis and antidepressive therapy. One of them is endocannabinoid system, which has been proposed as a manager of emotional homeostasis, and thus, endocannabinoid alterations have been found in animals undergoing various preclinical models of depression procedures as well as in humans suffering from depressive-like disorders. In this review article, studies regarding those alterations have been summed up and analyzed. Another important issue raised by the researchers is the impact of currently used antidepressive drugs on endocannabinoid system so that it would be possible to predict reversibility of endocannabinoid alterations following stress exposure and, in the future, to be able to design individually personalized therapies. Preclinical studies investigating this topic have been analyzed and described in this article. Unfortunately, too few clinical studies in this field exist, what indicates an urgent need for collecting such data, so that it would be possible to compare them with preclinical outcomes and draw reliable conclusions.
Keywords: Animal model of depression; Antidepressant drugs; Depression; Early life stress; Endocannabinoid system.
© 2024. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.
References
-
- Abelaira HM, Réus GZ, Quevedo J (2013) Animal models as tools to study the pathophysiology of depression. Braz J Psychiatry 35(Suppl 2):S112–S120. https://doi.org/10.1590/1516-4446-2013-1098 - DOI - PubMed
-
- Aguado T, Monory K, Palazuelos J, Stella N, Cravatt B, Lutz B, Marsicano G, Kokaia Z, Guzmán M, Galve-Roperh I (2005) The endocannabinoid system drives neural progenitor proliferation. FASEB J : Off Publ Fed Am Soc Exper Biol 19(12):1704–1706. https://doi.org/10.1096/fj.05-3995fje - DOI
-
- Amancio-Belmont O, Becerril Meléndez AL, Ruiz-Contreras AE, Méndez-Díaz M, Prospéro-García O (2020) Maternal separation plus social isolation during adolescence reprogram brain dopamine and endocannabinoid systems and facilitate alcohol intake in rats. Brain Res Bull 164:21–28. https://doi.org/10.1016/j.brainresbull.2020.08.002 - DOI - PubMed
-
- Atsak P, Hauer D, Campolongo P, Schelling G, McGaugh JL, Roozendaal B (2012) Glucocorticoids interact with the hippocampal endocannabinoid system in impairing retrieval of contextual fear memory. Proc Natl Acad Sci U S A 109(9):3504–3509. https://doi.org/10.1073/pnas.1200742109 - DOI - PubMed - PMC
-
- Atsak P, Morena M, Schoenmaker C, Tabak E, Oomen CA, Jamil S, Hill MN, & Roozendaal B. (2018). Glucocorticoid-endocannabinoid uncoupling mediates fear suppression deficits after early-life stress. Psychoneuroendocrinology, 91:41–49. https://doi.org/10.1016/j.psyneuen.2018.02.021
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials